Aurinia Pharmaceuticals
AUPH
AUPH
72 hedge funds and large institutions have $136M invested in Aurinia Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 21 reducing their positions, and 8 closing their positions.
Holders
72
Holders Change
-1
Holders Change %
-1.37%
% of All Funds
1.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
19
Reduced
21
Closed
8
Calls
$8.66M
Puts
$8.18M
Net Calls
+$477K
Net Calls Change
-$2.07M
Top Buyers
| 1 |
HM
1
HealthCor Management
New York
|
$4.45M |
| 2 |
2
Goldman Sachs
New York
|
$8.83M |
| 3 |
3
Millennium Management
New York
|
$2.98M |
| 4 |
4
Victory Capital Management
San Antonio,
Texas
|
$1.45M |
| 5 |
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$3.43M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Walleye Trading
New York
| – | -$62K | -9,425 | Closed |
|
77
Canada Life
Winnipeg,
Manitoba, Canada
| – | -$43K | -6,730 | Closed |
|
78
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$13K | -1,950 | Closed |
|
79
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$10K | -1,621 | Closed |
|
|
GCM
80
Gables Capital Management
Miami,
Florida
| – | -$6K | -850 | Closed |
|